Acadia Healthcare (NASDAQ:ACHC) Sets New 52-Week Low - Here's What Happened

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) reached a new 52-week low during trading on Monday . The stock traded as low as $21.64 and last traded at $21.51, with a volume of 698316 shares changing hands. The stock had previously closed at $23.91.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Mizuho lowered their price objective on Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a research report on Tuesday, March 25th. Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Guggenheim initiated coverage on shares of Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective on the stock. Finally, Bank of America dropped their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $50.39.

Acadia Healthcare Trading Up 2.3 %

The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.00 billion, a PE ratio of 7.14, a P/E/G ratio of 1.46 and a beta of 1.13. The business has a fifty day moving average price of $30.17 and a 200 day moving average price of $39.18.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Envestnet Portfolio Solutions Inc. acquired a new position in Acadia Healthcare during the first quarter worth approximately $222,000. GAMMA Investing LLC boosted its stake in shares of Acadia Healthcare by 143.8% during the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company's stock worth $176,000 after buying an additional 3,428 shares during the period. UMB Bank n.a. grew its holdings in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after buying an additional 755 shares during the last quarter. Congress Asset Management Co. raised its stake in Acadia Healthcare by 24.7% during the 1st quarter. Congress Asset Management Co. now owns 173,517 shares of the company's stock valued at $5,261,000 after acquiring an additional 34,328 shares during the last quarter. Finally, Phocas Financial Corp. lifted its position in Acadia Healthcare by 30.6% during the 4th quarter. Phocas Financial Corp. now owns 94,320 shares of the company's stock worth $3,740,000 after acquiring an additional 22,095 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.